IFIH1 and interstitial lung disease: One of these MSA, the anti-melanoma differentiation-associated gene 5 (MDA5) antibodies (Abs), was originally identified in a specific subset of DM, named clinically amyopathic DM (CADM), associated with an increased risk for rapidly progressive interstitial lung disease (RP-ILD).